Precision Medicine on a Budget in Africa: using existing genetic data to mitigate adverse drug reactions to conventional cancer drugs.
Alexandra Lindsey Djomkam Zune , Charles Ochieng’ Olwal, Emmanuel Agbeli , Abdoulaye Baniré Diallo , Emmanuella Amoako, Yaw Bediako , Lily Paemka. Abstract Variations in drug-metabolizing enzymes and transporters are associated with adverse drug reactions (ADRs). ADRs to cancer drugs can differ among populations owing to environmental and genetic differences. Due to limited resources and prohibitive costs associated with drug development, African countries rely on […]
Yemaachi Biotech and Illumina Announce the Arrival of the NovaSeq X Plus in Ghana
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
A Bold Step into Building Africa’s Cancer Atlas.
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Tackling Bias in Health- BBC World Service.
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
African Cancer Database Debuts
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
A Ghanaian Scientist’s Quest to Create a Genetic Map of Cancer in Africa
Sequencing the human genome enables scientists to study human biology in a granular fashion and use that information to create treatments for things like cancer. Yet, of the human genomes studied so far, only 2% have been those of Africans. Yemaachi Biotech company in Ghana is addressing that through its Africa Cancer Atlas, partnering with […]
Yemaachi Biotech, the Ghanaian Company Building the “African Cancer Atlas”
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
‘The Field of Human Ancestry is Rife with Racism’: Pioneering Project to Build Cancer Database in Africa.
When Yaw Bediako lost his father to liver cancer, it set the Ghanaian immunologist on a journey to know more about the disease. He quickly realised the burden of cancer in Africa was much greater than he had thought – accounting for about 700,000 deaths every year – and that very few scientific papers about the disease […]